SCHEMBL8766483

SCHEMBL8766483

CS(=O)(=O)c1ccc(C(=O)CN2CCC2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.47
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
ABCB1 P08183 1/20 0.42
LMNA P02545 1/20 0.41
PTGS1 P23219 1/20 0.40
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 2/20 0.39
MAPT P10636 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766778 0.78 RAB9A (0.41) LMNARAB9ASMN1; SMN2HTTMAPT
SCHEMBL8766644 0.78 HAO1 (0.43) MMP2MMP9MMP8LMNARAB9A
SCHEMBL8767909 0.75 L3MBTL1 (0.49) LMNASMN1; SMN2
SCHEMBL24634980 0.73 PKM (0.56) LMNARAB9ASMN1; SMN2HTTMAPT
SCHEMBL1185872 0.70 GSR (0.61) GSRMMP2MMP9MMP8SMN1; SMN2
SCHEMBL5058142 0.70 GSR (0.61) GSRMMP2MMP9MMP8
SCHEMBL5739537 0.70 RAB9A (0.69) LMNARAB9ASMN1; SMN2HTTMAPT
SCHEMBL5739984 0.70 RAB9A (0.69) RAB9ASMN1; SMN2HTTMAPTKMT2A
SCHEMBL5738542 0.70 ALDH1A1 (0.54) LMNARAB9ASMN1; SMN2HTTMAPT
SCHEMBL8444585 0.70 POLB (0.63) LMNAHTTMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788478-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-08-13 EP disclosed